Trial intelligence / Profile preview

Isolation of HPV-reactive or other tumor-reactive T-cell receptors in cervix, vulva, and oropharyngeal cancer

NL-OMON57742Recruiting

Sponsor
Netherlands Cancer Institute
Start
Jul 2016
Countries
1
01

Overview

Open-label, single-arm trial in Cervical Cancer (CC), Vulval carcinoma, oropharyngeal cancer and 1 more, sponsored by Netherlands Cancer Institute. Started Jul 2016; status: recruiting.

02

Conditions

Cervical Cancer (CC)Vulval carcinomaoropharyngeal cancerhead and neck cancer (HNC)

Beyond the preview

Go deeper on NL-OMON57742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON57742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call